View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
FRIDAY, Dec. 14 (HealthDay News) -- Omega-3 fatty acid (n-3FA) supplements do not correlate with higher perioperative blood loss during spinal fusion procedures, according to a study published in the December issue of the European Spine Journal.
Dennis S. Meredith, M.D., from the Hospital for Special Surgery in New York City, and colleagues retrospectively examined the effect of n-3FA supplementation on bleeding in all one- or two-level posterolateral lumbar decompression/fusions, with or without interbody fusion, conducted by five surgeons over three years. Twenty-eight patients taking n-3FA supplements were matched (1:2) with controls, after exclusion of patients with abnormal coagulation parameters, bleeding disorders, or taking other medications. Supplements were stopped an average of 5.2 days before surgery.
The researchers observed no significant differences in the mean estimated blood loss or the mean transfused volume of Cell Saver between the n-3FA group and the control group. The groups were also similar with respect to secondary outcomes, including drop in postoperative hemoglobin, requirement for transfusion, complications, and surgical drain output.
"Ultimately, the value of this study is that it does not demonstrate a safety issue that would prevent future studies designed to assess the risk/benefit ratio of n-3FA supplements during spinal surgery," the authors write.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top